Search research articles
Contact Us
Filters
Showing results (51-60 of 79) with videos related to
Page
of 8
Sort By:
Clinical Genitourinary Cancer
|
December 11, 2024
Development and Validation of Prognostic Model for Metastatic Castration-Resistant Prostate Cancer Patients Treated With First-Line Abiraterone or Enzalutamide
Orazio Caffo, Umberto Basso, Carlo Cattrini, et al.
Future Oncology (London, England)
|
April 28, 2025
Prognostic factors of long-term response to androgen receptor signaling inhibitors used as first-line treatment for mCRPC
Antonello Veccia, Umberto Basso, Carlo Cattrini, et al.
Targeted Oncology
|
May 10, 2021
The Role of p53 Expression in Patients with RAS/BRAF Wild-Type Metastatic Colorectal Cancer Receiving Irinotecan and Cetuximab as Later Line Treatment
Pina Ziranu, Eleonora Lai, Marta Schirripa, et al.
Scientific Reports
|
June 19, 2026
Clinical and pathological predictors of early recurrence after neoadjuvant cisplatin gemcitabine in muscle invasive bladder cancer in the RealBLADDER study
Giandomenico Roviello, Elisabetta Gambale, Roberta Giorgione, et al.
Critical Reviews in Oncology/Hematology
|
December 3, 2020
Introducing immunotherapy for advanced hepatocellular carcinoma patients: Too early or too fast?
Eleonora Lai, Giorgio Astara, Pina Ziranu, et al.
Cancers
|
May 28, 2020
From CENTRAL to SENTRAL (SErum aNgiogenesis cenTRAL): Circulating Predictive Biomarkers to Anti-VEGFR Therapy
Riccardo Giampieri, Pina Ziranu, Bruno Daniele, et al.
Tumori
|
November 27, 2020
Retrospective survival analysis in patients with metastatic pancreatic ductal adenocarcinoma with insulin-treated type 2 diabetes mellitus
Andrea Pretta, Pina Ziranu, Marco Puzzoni, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology
|
September 30, 2021
Lenvatinib versus Sorafenib as first-line treatment in hepatocellular carcinoma: A multi-institutional matched case-control study
Margherita Rimini, Shigeo Shimose, Sara Lonardi, et al.
Cancers
|
April 13, 2024
Prediction of Response to Anti-Angiogenic Treatment for Advanced Colorectal Cancer Patients: From Biological Factors to Functional Imaging
Giuseppe Corrias, Eleonora Lai, Pina Ziranu, et al.
Scientific Reports
|
March 17, 2023
CDX-2 expression correlates with clinical outcomes in MSI-H metastatic colorectal cancer patients receiving immune checkpoint inhibitors
Pina Ziranu, Andrea Pretta, Marta Pozzari, et al.
Page
of 8
Search research articles
Search
Showing results (51-60 of 79) with videos related to
Sort By:
Page
of 8
Clinical Genitourinary Cancer
|
December 11, 2024
Development and Validation of Prognostic Model for Metastatic Castration-Resistant Prostate Cancer Patients Treated With First-Line Abiraterone or Enzalutamide
Orazio Caffo, Umberto Basso, Carlo Cattrini, et al.
Future Oncology (London, England)
|
April 28, 2025
Prognostic factors of long-term response to androgen receptor signaling inhibitors used as first-line treatment for mCRPC
Antonello Veccia, Umberto Basso, Carlo Cattrini, et al.
Targeted Oncology
|
May 10, 2021
The Role of p53 Expression in Patients with RAS/BRAF Wild-Type Metastatic Colorectal Cancer Receiving Irinotecan and Cetuximab as Later Line Treatment
Pina Ziranu, Eleonora Lai, Marta Schirripa, et al.
Scientific Reports
|
June 19, 2026
Clinical and pathological predictors of early recurrence after neoadjuvant cisplatin gemcitabine in muscle invasive bladder cancer in the RealBLADDER study
Giandomenico Roviello, Elisabetta Gambale, Roberta Giorgione, et al.
Critical Reviews in Oncology/Hematology
|
December 3, 2020
Introducing immunotherapy for advanced hepatocellular carcinoma patients: Too early or too fast?
Eleonora Lai, Giorgio Astara, Pina Ziranu, et al.
Cancers
|
May 28, 2020
From CENTRAL to SENTRAL (SErum aNgiogenesis cenTRAL): Circulating Predictive Biomarkers to Anti-VEGFR Therapy
Riccardo Giampieri, Pina Ziranu, Bruno Daniele, et al.
Tumori
|
November 27, 2020
Retrospective survival analysis in patients with metastatic pancreatic ductal adenocarcinoma with insulin-treated type 2 diabetes mellitus
Andrea Pretta, Pina Ziranu, Marco Puzzoni, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology
|
September 30, 2021
Lenvatinib versus Sorafenib as first-line treatment in hepatocellular carcinoma: A multi-institutional matched case-control study
Margherita Rimini, Shigeo Shimose, Sara Lonardi, et al.
Cancers
|
April 13, 2024
Prediction of Response to Anti-Angiogenic Treatment for Advanced Colorectal Cancer Patients: From Biological Factors to Functional Imaging
Giuseppe Corrias, Eleonora Lai, Pina Ziranu, et al.
Scientific Reports
|
March 17, 2023
CDX-2 expression correlates with clinical outcomes in MSI-H metastatic colorectal cancer patients receiving immune checkpoint inhibitors
Pina Ziranu, Andrea Pretta, Marta Pozzari, et al.
Page
of 8